A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
Clinical trial NCT06672393 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06672393
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2025-10-22
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.